We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

FDA Breast Implant Decisions Cleared By Senate Panel

Law360 (July 31, 2006, 12:00 AM EDT) -- One year after the U.S. Food and Drug Administration gave two companies conditional approval to market silicone breast implants, a U.S. Senate panel has concluded after conducting an investigation into alleged improprieties that the agency’s decisions regarding the controversial product should not be reversed.

Chairman Michael B. Enzi of the Senate Health, Education, Labor and Pensions Committee released the findings of an investigation late last week in a report titled “Pre-Market Approval Applications for Silicone Breast Implants.”

The probe was prompted after more than two dozen...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.